Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 12:20 save search
Potential of Arvinas’ PROTAC® AR Degraders Reinforced by 11.1 months rPFS with Bavdegalutamide and Updated Positive Interim Data from Second Generation ARV-766 in mCRPC
Published: 2023-10-22 (Crawled : 12:20) - globenewswire.com
ARVN | $34.72 -4.33% -4.58% 650K
|
Health Technology
| Email alert
Add to watchlist
arv-766 protac positive potential
Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1
Published: 2023-10-07 (Crawled : 12:20) - prnewswire.com
RNA | $23.91 -0.75% -0.75% 870K
|
Health Technology
| Email alert
Add to watchlist
favorable positive
BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) at European Society of Cardiology Congress 2023
Published: 2023-08-27 (Crawled : 12:20) - globenewswire.com
BBIO | $25.77 -3.95% -3.99% 1.9M
|
Health Technology
| Email alert
Add to watchlist
positive cardiology results study
LM Funding America, Inc. Achieves Over 1,260% Year-Over-Year Revenue Growth to $3.2 Million and Generates Positive Core EBITDA for the Second Quarter of 2023
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
LMFA | $2.62 -7.09% -7.63% 42K
|
Commercial Services
|
| O: 2.03%
H: 0.0%
C: -13.36%
positive funding growth
FDA Approves J&J’s Akeega for BRCA-Positive Prostate Cancer
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
fda cancer
Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
MBOT | $1.01 0.0% 180K
|
Health Technology
|
| O: 0.97%
H: 1.44%
C: 0.48%
medical
Acorn Achieves Net Income and Positive Cash Flow as Q2 Revenue Rises 22% from Remote Monitoring and Control Solutions for Backup Generators and Gas Pipelines
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
ACFN | $7.2 -0.69% -95.92% 0
|
Professional, Scientific, and T...
|
| O: 3.33%
H: 17.9%
C: 12.9%
control positive gas solutions flow
Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
Published: 2023-08-08 (Crawled : 12:20) - globenewswire.com
SILO | $1.93 -2.03% -2.07% 32K
|
Finance and Insurance
|
| O: 13.64%
H: 22.0%
C: -8.0%
spc-15 pharma positive disorders milestone spc-14
Adamas One Enters into a Letter of Intent to Acquire a Key Diamond Manufacturing Company, Solidifying Its Position as a Leader in the Lab-Grown Diamond Market
Published: 2023-08-08 (Crawled : 12:20) - globenewswire.com
JEWL | $0.3602 -6.0% -6.0% 24K
|
n/a
|
| O: -3.4%
H: 2.46%
C: -1.76%
one acquire market
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
Published: 2023-08-02 (Crawled : 12:20) - globenewswire.com
YTEN | $0.291 -6.19% -6.6% 430K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: -7.73%
test positive bioscience results market
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma
Published: 2023-07-21 (Crawled : 12:20) - biospace.com/
BMY | $48.51 0.48% -0.02% 9.8M
|
Health Technology
|
| O: 0.19%
H: 1.41%
C: 1.24%
melanoma chmp opdivo approval positive treatment
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients
Published: 2023-07-20 (Crawled : 12:20) - globenewswire.com
GRFS | $6.54 -0.31% 0.0% 1.3M
|
Health Technology
|
| O: -2.19%
H: 2.83%
C: 2.54%
xembify positive topline results study
Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
DERM | $4.02 -9.05% -10.5% 130K
|
|
| O: 0.35%
H: 4.91%
C: -17.19%
FBIO | $1.82 1.11% 0.55% 340K
|
Health Technology
|
| O: -0.61%
H: 3.47%
C: -1.77%
dfd-29 corporation positive treatment trials topline medical results
Daré Bioscience Announces Additional Positive Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
DARE | $0.4801 2.28% 2.21% 200K
|
Health Technology
|
| O: -0.62%
H: 5.25%
C: 2.4%
positive bioscience women study
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer Patients
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
PPBT | $0.6143 0.65% 180K
|
Manufacturing
|
| O: -6.04%
H: 6.43%
C: -1.79%
cm24 biotech positive cancer pancreatic purple results
SELLAS Life Sciences Reports Positive Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
SLS | $1.325 -1.12% -1.52% 810K
|
Health Technology
|
| O: -0.61%
H: 3.68%
C: -0.61%
opdivo life positive sciences study
89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) in Nature Medicine
Published: 2023-06-24 (Crawled : 12:20) - globenewswire.com
ETNB | $9.49 -3.36% -3.48% 670K
|
Health Technology
| Email alert
Add to watchlist
positive trial results phase 2
Horizon Therapeutics plc Announces Positive Topline Data from Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2023-06-22 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.25%
H: 0.75%
C: 0.04%
tepezza disease active japan positive treatment thyroid topline eye trial therapeutics
SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023
Published: 2023-06-21 (Crawled : 12:20) - globenewswire.com
SABS | $4.51 -3.53% -3.66% 3.1K
|
|
| O: -1.14%
H: 1.15%
C: -1.25%
sab-142 positive diabetes study
Journey Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
DERM | $4.02 -9.05% -10.5% 130K
|
|
| O: 8.98%
H: 32.97%
C: 12.09%
FBIO | $1.82 1.11% 0.55% 340K
|
Health Technology
|
| O: -0.85%
H: 4.27%
C: 1.54%
dfd-29 corporation positive topline impact medical trial
Gainers vs Losers
| 48% | 52% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 1.6M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.